FraserISLanghamSUhl-HochgraeberK.Health-related quality of life and economic burden of abnormal uterine bleeding. Expert Rev Obstet Gynecol. 2009;4:179-189.
3.
LidegaardØLøkkegaardEJensenASkovlundCWKeidingN. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257-2266.
4.
MansourD.Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism. J Fam Plann Reprod Health Care. 2012;38:148-149.
5.
RottH.Thrombotic risks of oral contraceptives. Curr Opin Obstet Gynecol. 2012;24:235-240.
6.
KimRJBeckerRC.Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146:948-957.
7.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.